À propos de ce poste BDR – VITL Clinical Sales chez VITL
Business Development Representative – VITL Clinical Sales
Location: flexible, remote
Reports to: Justyn Dow - Head of Sales
Type: Full-time
Role Overview
VITL is building the operating system for modern clinics. Simple workflows, clean data, and pharmacy infrastructure that doesn’t fight you. We’re scaling fast, and we need a BDR who knows how to create momentum—someone who can take a cold lead, warm it, and hand it over burning hot. This is outbound-first, curiosity-driven, and grounded in real conversations with real prescribers and clinics. No spray-and-pray. No scripts. Just smart outreach, consistent follow-through, and a feel for where the opportunity lives
What You’ll Own
Build and manage a strong top-of-funnel pipeline through targeted outbound (email, calls, LinkedIn, referrals).
Understand VITL’s product, the clinic workflow, and the value drivers well enough to run early discovery and spot real fit.
Partner closely with Sales, Customer Success, and Product to surface insights from the field.
Maintain crisp, accurate notes and pipeline hygiene—because signal matters.
Hit weekly activity targets and monthly qualified-opportunity goals. No drama. Just performance.
Experiment with new sequences, messaging angles, outreach rhythms, and vertical-specific tactics.
Represent the VITL brand with confidence, clarity, and credibility.
Top KPIs
Qualified Opportunities Generated — the number of sales-accepted, high-probability meetings delivered each month.
Outbound Conversion Rate — percentage of outbound touches that turn into real conversations and qualified opportunities.
Pipeline Quality & Hygiene — accuracy, completeness, and timeliness of CRM data; no ghosts, no fluff, no mystery leads.
What Good Looks Like
You consistently deliver qualified meetings that convert—not calendar filler.
You learn the clinic/prescriber landscape and speak the language fluently.
You treat pipeline like a craft, not a chore.
You bring back insights the team uses to sharpen product, pricing, and positioning.
You make Sales’ job easier. You make Marketing smarter. You make the company faster and more accurate.
Must-Haves
1–3 years in BDR/SDR or adjacent roles in a high-growth SaaS environment.
Proven ability to generate and qualify pipeline through outbound.
Strong writing and communication skills—you know how to punch through noise.
Comfortable in a startup: ambiguity, speed, autonomy.
Curious, competitive, and resilient. You don’t wilt when someone says no.
Nice-to-Haves
Experience selling into healthcare, clinics, prescribers, or health-tech.
Familiarity with CRM workflows (HubSpot) and outbound automation tools.
A point of view on great sales craft—because you’ve been in the trenches.
Compensation
The base salary range for this role is competitive and will be determined based on the candidate’s relevant skills, experience, and geographic location. In addition to base pay, total compensation may include performance-based incentives, benefits and company options.
Security, Privacy & Compliance
This role may handle PHI/PII and must follow HIPAA, company privacy policies, and least-privilege access practices.
EEO & Inclusion
VITL is an Equal Opportunity Employer. We consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, or other legally protected characteristics. If you meet most—but not all—requirements, we encourage you to apply.
About VITL
VITL is a Nashville-based healthtech company providing beautifully simple e-prescribing infrastructure for cash-pay medical practices. Through its open pharmacy marketplace, VITL connects clinics with verified 503A compounding pharmacies nationwide, enabling real-time price comparison, multi-pharmacy ordering, and Amazon-style patient tracking, all through a single, elegant interface. Founded in 2024, VITL serves over 700 clinics representing 175,000 patients across the United States. VITL is backed by Signalfire, a San Francisco based venture capital firm with $3B in AUM, which led its Series A in late 2025.
